Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression. | Int J Mol Sci | 2023 | 37834160 | PubTator, text mining | PubMed |
| Histone and Histone Acetylation-Related Alterations of Gene Expression in Uninvolved Psoriatic Skin and Their Effects on Cell Proliferation, Differentiation, and Immune Responses. | Int J Mol Sci | 2023 | 37833997 | PubTator, text mining | PubMed |
| Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets. | Cells | 2023 | 37830606 | PubTator, text mining | PubMed |
| Low microsatellite instability: A distinct instability type in gastric cancer? | J Cancer Res Clin Oncol | 2023 | 37819581 | PubTator, text mining | PubMed |
| SIN-3 acts in distinct complexes to regulate the germline transcriptional program in Caenorhabditis elegans. | Development | 2023 | 37818613 | PubTator, text mining | PubMed |
| Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review. | Langenbecks Arch Surg | 2023 | 37816905 | PubTator, text mining | PubMed |
| Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. | Sci Rep | 2023 | 37816854 | PubTator, text mining | PubMed |
| Clinical Updates for Gastrointestinal Malignancies. | J Pers Med | 2023 | 37763191 | PubTator, text mining | PubMed |
| Identifying Molecular Roadblocks for Transcription Factor-Induced Cellular Reprogramming In Vivo by Using C. elegans as a Model Organism. | J Dev Biol | 2023 | 37754839 | PubTator, text mining | PubMed |
| A computational framework for the inference of protein complex remodeling from whole-proteome measurements. | Nat Methods | 2023 | 37749212 | PubTator, text mining | PubMed |
| HPC-Atlas: Computationally Constructing A Comprehensive Atlas of Human Protein Complexes. | Genomics Proteomics Bioinformatics | 2023 | 37730114 | PubTator, text mining | PubMed |
| Pulse-SILAC and Interactomics Reveal Distinct DDB1-CUL4-Associated Factors, Cellular Functions, and Protein Substrates. | Mol Cell Proteomics | 2023 | 37689310 | PubTator, text mining | PubMed |
| Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer. | Cancers (Basel) | 2023 | 37686649 | PubTator, text mining | PubMed |
| Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis. | Biochem Biophys Rep | 2023 | 37664524 | PubTator, text mining | PubMed |
| SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. | J Clin Invest | 2023 | 37655663 | PubTator, text mining | PubMed |
| Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer. | Theranostics | 2023 | 37649598 | PubTator, text mining | PubMed |
| Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins. | Pharmaceuticals (Basel) | 2023 | 37631029 | PubTator, text mining | PubMed |
| Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options. | Biomedicines | 2023 | 37626654 | PubTator, text mining | PubMed |
| Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. | Genome Biol | 2023 | 37612728 | PubTator, text mining | PubMed |
| The oncogene Musashi1 encodes novel miRNAs in breast cancer. | Sci Rep | 2023 | 37607966 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=15